Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks

PHASE3CompletedINTERVENTIONAL
Enrollment

623

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Migraine Disorders
Interventions
DRUG

sumatriptan succinate/naproxen sodium

comparator

DRUG

placebo

placebo to match

Trial Locations (52)

10021

GSK Investigational Site, New York

10467

GSK Investigational Site, The Bronx

11580

GSK Investigational Site, Valley Stream

11803

GSK Investigational Site, Plainview

12206

GSK Investigational Site, Albany

14609

GSK Investigational Site, Rochester

19114

GSK Investigational Site, Philadelphia

27401

GSK Investigational Site, Greensboro

27599

GSK Investigational Site, Chapel Hill

27609

GSK Investigational Site, Raleigh

29621

GSK Investigational Site, Anderson

30033

GSK Investigational Site, Decatur

30165

GSK Investigational Site, Rome

30342

GSK Investigational Site, Atlanta

32119

GSK Investigational Site, South Daytona

33024

GSK Investigational Site, Pembroke Pines

33173

GSK Investigational Site, Miami

34996

GSK Investigational Site, Stuart

35406

GSK Investigational Site, Tuscaloosa

36207

GSK Investigational Site, Anniston

37043

GSK Investigational Site, Clarksville

37620

GSK Investigational Site, Bristol

38105

GSK Investigational Site, Memphis

43081

GSK Investigational Site, Westerville

45069

GSK Investigational Site, West Chester

45219

GSK Investigational Site, Concinnati

47712

GSK Investigational Site, Evansville

48104

GSK Investigational Site, Ann Arbor

55426

GSK Investigational Site, Saint Louis Park

60607

GSK Investigational Site, Chicago

63141

GSK Investigational Site, St Louis

70808

GSK Investigational Site, Baton Rouge

71913

GSK Investigational Site, Hot Springs

73104

GSK Investigational Site, Oklahoma City

76135

GSK Investigational Site, Fort Worth

78229

GSK Investigational Site, San Antonio

80304

GSK Investigational Site, Boulder

84121

GSK Investigational Site, Salt Lake City

85032

GSK Investigational Site, Phoenix

85201

GSK Investigational Site, Mesa

87108

GSK Investigational Site, Albuquerque

92056

GSK Investigational Site, Oceanside

92108

GSK Investigational Site, San Diego

92128

GSK Investigational Site, San Diego

92618

GSK Investigational Site, Irvine

97301

GSK Investigational Site, Salem

97401

GSK Investigational Site, Eugene

98195

GSK Investigational Site, Seattle

98405

GSK Investigational Site, Tacoma

98801

GSK Investigational Site, Wenatchee

06001

GSK Investigational Site, Avon

08057

GSK Investigational Site, Moorestown

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY